ICCC - Financial Reports List - ImmuCell Corporation - IntrinsicAlpha

ImmuCell Corporation ICCC

Healthcare - Biotechnology - NASDAQ - US

$ 5.42

-2.18 %

$ 48.7 M

Market Cap

-20.69

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	52.10%	145.18%	162.01%
Annual Report	FY	10-K	2024-12-31	51.64%	62.65%	71.47%
Quarterly Report	Q3	8-K	2024-09-30	11.40%	25.35%	-48453.35%
Quarterly Report	Q2	8-K	2024-06-30	54.92%	-11.01%	-6.29%
Quarterly Report	Q1	8-K	2024-03-31	110.58%	81.09%	86.70%
Quarterly Report	Q4	8-K	2023-12-31	30.30%	31.66%	38.61%
Annual Report	FY	10-K	2023-12-31	-5.90%	-131.54%	-150.03%
Quarterly Report	Q3	8-K	2023-09-30	12.52%	-43.51%	-91.90%
Quarterly Report	Q2	8-K	2023-06-30	-8.51%	-101.67%	-120.07%
Quarterly Report	Q1	8-K	2023-03-31	-42.55%	-314.69%	-284.50%

1